Dynocardia, Inc. research brief
CIK 1776173
Generated Nov. 2, 2026, 3:42 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NEWTON CENTER MA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Dec. 12, 2025 · D/A · 0001776173-25-000005 · Source evidence
Reported offering amount: 2000042 USD. Reported amount sold: 1240638 USD.
- Dec. 12, 2025 · D/A · 0001776173-25-000004 · Source evidence
Reported offering amount: 6000000 USD. Reported amount sold: 4759253 USD.
- March 20, 2025 · D/A · 0001776173-25-000002 · Source evidence
Reported offering amount: 5324676 USD. Reported amount sold: 3730000 USD.
- March 14, 2025 · D · 0001776173-25-000001 · Source evidence
Reported offering amount: 2000042 USD. Reported amount sold: 675324 USD.
- Jan. 6, 2025 · D/A · 0001488336-25-000001 · Source evidence
Reported offering amount: 6000000 USD. Reported amount sold: 3700000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Dynocardia, Inc. research brief,” CIK 1776173, retrieved Nov. 2, 2026, 3:42 p.m.. Cite the specific accessions used. No amounts have been summed.